AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?

AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?

The cytoprotective effects of MK-801 and NBQX, selective N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor antagonists, respectively, were compared both singularly and in combination in models of transient severe forebrain and transient focal c...

Descripció completa

Dades bibliogràfiques
Autors principals:	Buchan, A, Lesiuk, H, Barnes, K, Li, H, Huang, Z, Smith, K, Xue, D
Format:	Journal article
Idioma:	English
Publicat:	1993

Ítems similars

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
per: Xue, D, et al.
Publicat: (1994)

DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION
per: Xue, D, et al.
Publicat: (1992)

POSTISCHEMIC TREATMENT WITH AMPA, BUT NOT NMDA, ANTAGONISTS PREVENTS CA1 NEURONAL INJURY
per: Li, H, et al.
Publicat: (1992)

The rise and fall of NMDA antagonists for ischemic stroke.
per: Hoyte, L, et al.
Publicat: (2004)

NMDA antagonists: their role in neuroprotection.
per: Small, D, et al.
Publicat: (1997)

NMDA antagonists: their role in neuroprotection.
per: Small, D, et al.
Publicat: (1997)

Do NMDA antagonists prevent neuronal injury? No.
per: Buchan, A
Publicat: (1992)

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
per: Caitlyn J. Bartsch, et al.
Publicat: (2022-06-01)

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
per: Buchan, A, et al.
Publicat: (1992)

Neuroprotection, excitotoxicicity and nmda antagonists
per: RUBENS JOSÉ GAGLIARDI
Publicat: (2000-06-01)

Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
per: Buchan, A
Publicat: (1990)

INVERSE AGONISTS: MORE THAN JUST ANTAGONISTS?
per: R. N. Alyautdin, et al.
Publicat: (2022-06-01)

Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia.
per: Buchan, A, et al.
Publicat: (1991)

NMDA Receptor Antagonists for Treatment of Depression
per: Zeynep Ates-Alagoz, et al.
Publicat: (2013-04-01)

Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
per: Hicks, C, et al.
Publicat: (1999)

CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
per: Menniti, F, et al.
Publicat: (2003)

NEUROPROTECTIVE PROFILE OF FPL-15896AR, A NOVEL UNCOMPETITIVE NMDA ANTAGONIST
per: Murray, R, et al.
Publicat: (1995)

Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
per: Li, H, et al.
Publicat: (1993)

HYPOTHERMIA BUT NOT NMDA RECEPTOR ANTAGONIST MK-801 ATTENUATES NEURON DAMAGE - ARE THE RESULTS CONCLUSIVE - REPLY
per: Buchan, A, et al.
Publicat: (1992)

NMDA receptor antagonists in the treatment of neurological diseases
per: I. S. Preobrazhenskaya
Publicat: (2020-10-01)

PSYCHOPHARMACOLOGICAL PROFILE OF THE NMDA RECEPTOR ANTAGONIST MK-801
per: Iversen, S, et al.
Publicat: (1987)

Cold Pain Threshold and Role of NMDA Receptor Antagonists
per: Poroshat Nazemi, et al.
Publicat: (2019-01-01)

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
per: Gregory R. Tintinger, et al.
Publicat: (2010-01-01)

NMDA receptor antagonists can enhance or impair learning performance in animals.
per: Mondadori, C, et al.
Publicat: (1989)

NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments
per: I.S. Preobrazhenskaya
Publicat: (2014-10-01)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
per: Tetsuro Kikuchi
Publicat: (2020-07-01)

NMDA receptor antagonists as potential therapy in cerebellar degenerative disorders
per: Olga S. Belozor, et al.
Publicat: (2022-06-01)

Modulation of functional EEG networks by the NMDA antagonist nitrous oxide.
per: Levin Kuhlmann, et al.
Publicat: (2013-01-01)

NMDA receptor antagonist ketamine impairs feature integration in visual perception.
per: Julia D I Meuwese, et al.
Publicat: (2013-01-01)

Agonist hold Antagonist Protocol versus Antagonist Protocol in Intracytoplasmic Sperm Injection for Infertile Patients with Polycystic Ovary Syndrome
per: Hazem H. Ahmed, et al.
Publicat: (2022-01-01)

Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia
per: A. P. Pereverzev, et al.
Publicat: (2019-12-01)

Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice
per: Naser Osanloo, et al.
Publicat: (2015-10-01)

NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury.
per: Yang Li, et al.
Publicat: (2015-01-01)

Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain.
per: Carla M Yuede, et al.
Publicat: (2010-06-01)

NMDA-receptor antagonists disrupt the formation of the auditory space map in the mammalian superior colliculus.
per: Schnupp, J, et al.
Publicat: (1995)

Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemia
per: Gary K. Steinberg, et al.
Publicat: (1995-04-01)

Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
per: F. A. Zeiler
Publicat: (2015-01-01)

NMDA Receptor Antagonist Memantine Ameliorates Experimental Autoimmune Encephalomyelitis in Aged Rats
per: Biljana Bufan, et al.
Publicat: (2024-03-01)

NMDA Receptor-Antagonistic Properties of Hyperforin, a Constituent of St. John’s Wort
per: Vikas Kumar, et al.
Publicat: (2006-01-01)

Ammonia-mediated LTP inhibition: Effects of NMDA receptor antagonists and l-carnitine
per: Yukitoshi Izumi, et al.
Publicat: (2005-11-01)